Try our beta test site
411 studies found for:    HSV
Show Display Options
Rank Status Study
1 Recruiting Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Condition: Herpes Simplex
Intervention: Device: Vela Sentosa SA HSV1/2 Qualitative PCR Test
2 Active, not recruiting Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: HSV1716 Intra-pleural delivery
3 Recruiting HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Conditions: Rhabdomyosarcoma;   Osteosarcoma;   Ewing Sarcoma;   Soft Tissue Sarcoma;   Neuroblastoma;   Wilms Tumor;   Malignant Peripheral Nerve Sheath Tumor;   Clival Chordoma;   Non-CNS Solid Tumors
Intervention: Biological: HSV1716
4 Active, not recruiting HSV529 Vaccine in HSV-2 Seropositive Adults
Condition: Herpes Simplex Virus 2
Interventions: Biological: HSV529;   Drug: Valacyclovir
5 Terminated A Study of HSV Testing Among Pregnant Women
Conditions: Herpes Simplex;   Pregnancy
Interventions: Behavioral: Safer-sex counseling;   Procedure: Type specific serologic HSV testing
6 Recruiting Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
Condition: Herpes Simplex Virus
Intervention: Device: Genexpert assay
7 Completed Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Condition: Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
8 Active, not recruiting Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
Conditions: Genital Herpes;   Herpes Simplex Virus;   Herpes Simplex Virus Vaccines;   HSV Vaccines;   Herpesvirus Vaccines
Intervention: Biological: HSV529
9 Completed Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant;   Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
10 Withdrawn A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Condition: Herpes Simplex Virus
Interventions: Drug: Novel Antiviral Drug;   Drug: Placebo
11 Completed HSV Oral Reactivation in Children
Conditions: HSV-1;   HIV
Intervention: Other: Underlying medical illness
12 Completed Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Condition: Prophylaxis for Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK 208141;   Biological: Placebo
13 Completed
Has Results
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Condition: Herpes Simplex Type II
Interventions: Drug: TDF;   Drug: Placebo Vaginal Gel;   Drug: Vaginal TFV Gel;   Drug: Placebo Tablets
14 Completed Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon
Conditions: HIV-1 and HSV-2 Coinfection;   HIV Infections
Intervention: Drug: Acyclovir
15 Completed HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women
Condition: Pregnancy
Intervention: Other: testing for HSV 1 and 2 IgG type specific antibosy
16 Active, not recruiting Evaluating New Formulation of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2;   Biological: GEN-003;   Drug: Placebo
17 Terminated Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma
Interventions: Biological: oncolytic HSV-1716;   Drug: dexamethasone;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
18 Completed Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141;   Biological: Herpes simplex virus containing gD-Alum
19 Active, not recruiting Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Condition: Herpes Simplex Infections
Intervention:
20 Recruiting Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
Conditions: Recurrent Glioblastoma Multiforme;   Progressive Glioblastoma Multiforme;   Anaplastic Astrocytoma or Gliosarcoma
Intervention: Biological: M032 (NSC 733972)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.